LAS VEGAS, June 13, 2024 /PRNewswire/ -- JanOne Inc.
(Nasdaq: JAN), a multidisciplinary organization with a focus on
healthcare and fintech, released today its wholly-owned subsidiary,
ALT5 Sigma, transaction volume for April and May 2024.
According to the Company, ALT5 Sigma transaction volume reached
US$289 million for the months of
April and May 2024 combined, compared
to US$151 million in transaction
volume for the months of April and May
2023 combined, representing a year-over-year increase of
91%.
"Since inception, we have relied
solely on word-of-mouth and
client referrals to grow our business and have
managed a steady growth year-over-year, and now we begin to roll
out our global marketing strategies," said Andre Beauchesne, President of Alt5 Sigma. "The
adoption of cryptocurrencies in many industries is accelerating and
our B2B solutions can be easily integrated into all business
processes from checkout to payouts," further added Mr.
Beauchesne.
About ALT5 Sigma Inc.
Launched in 2018, ALT5 is a fintech
company that provides
next generation blockchain-powered technologies to enable
a migration to a new global financial paradigm. ALT5, through its
subsidiaries, offers two main platforms to its customers: "ALT5
Pay" and "ALT5 Prime". The Company processed over US$1.2 billion in cryptocurrency transactions in
2023.
ALT5 Pay is a crypto-currency payment gateway that enables
registered and approved global merchants to accept and make
crypto-currency payments or to integrate the ALT5 Pay payment
platform into their application or operations using the plugin with
WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants
have the option to convert to fiat currency (s) automatically or to
receive their payment in digital assets.
ALT5 Prime is an electronic over-the-counter trading platform
that enables registered and approved customers to buy and sell
digital assets. Customers can purchase digital assets with fiat
and, equally, can sell digital assets and receive fiat. ALT5 Prime
is available through a browser-based access mobile phone
application named "ALT5 Pro" that can be downloaded from the Apple
App Store, from Google Play, through ALT5 Prime's FIX API, as well
as through Broadridge Financial Solutions' NYFIX
gateway for approved customers.
About JanOne
JanOne is a unique Nasdaq-listed multidisciplinary organization
with a focus on healthcare and fintech. JanOne is one of the
constituents of the Russell Microcap Index, starting June 28, 2024. Through its biotech
activities, JanOne is developing innovative, actionable
solutions intended to help end the opioid crisis. JanOne is
dedicated to funding resources toward innovation, technology, and
education to find a key resolution to the national opioid epidemic,
which is one of the deadliest and most widespread in the nation's
history. Its drugs in the clinical trial pipeline have shown
promise for their innovative targeting of the causes of pain as a
strategic option for physicians averse to exposing patients to
addictive opioids.
JanOne's ALT5 subsidiary is a global fintech that provides next
generation blockchain powered technologies for the trading,
clearing, settlement, payment, and custodianship of digital
instruments.
Please visit www.janone.com
for additional information.
Forward Looking Statements
This press release contains statements that are forward-looking
statements as defined within the Private Securities Litigation
Reform Act of 1995, including, but not limited to, statements
relating to the statements that JAN 101 will treat PAD, that JAN
123 will treat CRPS, the timing of the commencement of clinical
trials, that the FDA will permit approval through a 505(b)(2)
pathway for JAN 123, that upon approval JAN 101 will immediately
disrupt the PAD market, and other statements, including words such
as "continue", "expect", "intend", "will", "hope" "should",
"would", "may", "potential", and other similar expressions. This
press release also contains statements and links relating to the
profitability and prospective growth of ALT5's platforms and
business, including, but not limited to international currency
risks, third-party or customer credit risks, liability claims
stemming from Alt5's services, and technology challenges for future
growth or expansion. Such statements reflect JanOne's current
view with respect to future events, are subject to risks and
uncertainties, and are necessarily based upon a number of estimates
and assumptions that, while considered reasonable by JanOne, are
inherently subject to significant business, economic, competitive,
political and social uncertainties and contingencies.
Many factors could cause JanOne's actual results, performance or
achievements to be materially different from any future results,
performance or achievements described in this press release. Such
factors could include, among others, those detailed in the
Company's periodic reports filed with the Securities and Exchange
Commission (the "SEC"). Should one or more of these risks or
uncertainties materialize, or should the assumptions set out in the
section entitled "Risk Factors" in JanOne's filings with the
SEC underlying those forward-looking statements prove incorrect,
actual results may vary materially from those described herein.
These forward-looking statements are made as of the date of this
press release and JanOne does not intend, and does not assume
any obligation, to update these forward-looking statements, except
as required by law. JanOne cannot assure that such statements will
prove to be accurate as actual results and future events could
differ materially from those anticipated in such statements.
Individuals are cautioned that forward-looking statements are not
guarantees of future performance and accordingly investors are
cautioned not to put undue reliance on forward-looking statements
due to the inherent uncertainty therein.
Media Contact Investor Relations
IR@janone.com
1-800-400-2247
Logo -
https://mma.prnewswire.com/media/973662/4759853/JanOne_With_4C_TM_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/janones-subsidiary-alt5-reports-91-year-over-year-increase-in-transaction-volume-to-us-289-million-for-april-and-may-2024-302171491.html
